Introduction and Objective: Early diabetic retinopathy (DR) is associated with inflammation and retinal neurodegeneration, which begin prior to overt microvascular pathology. Cannabinoid (CB) receptor 2 agonism has been shown to have anti-inflammatory and neuroprotective properties in the central nervous system. This study tested the potential of CB2-selective agonists HU-308 and CB65 to reduce inflammation and […]
Read MoreCategory: Diabetes
1235-OR: Gestational Diabetes Diagnosis Using Continuous Glucose Monitoring at 24–28 Weeks’ Gestation
Introduction and Objective: Data are limited as to whether continuous glucose monitoring (CGM) can be used to accurately diagnose gestational diabetes mellitus (GDM). We aimed to develop GDM diagnostic criteria based on CGM metrics at 24-28 weeks’ gestation.Methods: Planned analysis of a longitudinal, multi-site prospective cohort of gravidas without pregestational diabetes who wore a blinded […]
Read More1228-OR: First-in-Human Study Demonstrates GIP Receptor (GIPR) Antagonist AT7687 as Well-Tolerated and Suitable for Once-Weekly Subcutaneous Injection for Treatment in People Living with Obesity
Introduction and Objective: AT7687 is a first-in-class peptide GIPR antagonist validated as anti-obesity therapy in obese monkeys, as monotherapy and in combination with liraglutide and cagrilintide. This randomized, double-blind, placebo-controlled study evaluated the safety, pharmacokinetics (PK), and pharmacodynamics of AT7687 (AT).Methods: In the single ascending dose (SAD) part, 60 participants randomized 6:2 by cohort received […]
Read More1265-OR: Tirzepatide: Effect on Insulin Resistance and Human Fat Cells
Introduction and Objective: We tested the hypothesis that tirzepatide (TZ), a dual GLP-1/GIP agonist, improves metabolic health independent of weight loss via GIP effects on adipose cells. Dual GLP-1/GIP agonists are known to lower blood glucose to a greater degree than selective GLP-1 agonists. We quantified insulin resistance (IR) and adipose cell function after 6 […]
Read More1264-OR: Launch of the First Fully Remote Type 1 Diabetes Screening Program: Integration of a Novel, Scalable Genetic Risk Score and At-Home Monitoring with Autoantibody Testing and Psychosocial Support
Introduction and Objective: Early type 1 diabetes (T1D) detection is vital to prevent DKA, which affects 60% of pediatric cases. However, traditional screening relies on invasive blood draws, limiting accessibility for young children. We launched the first “fully remote” T1D screening program designed for large-scale implementation using a novel genetic stratification tool alongside online monitoring […]
Read More1250-OR: Efficacy of a Food Is Medicine Program in Low-Income, High-Risk Adults with Type 2 Diabetes: The KP ENRICH Study
Introduction and Objective: Food Is Medicine interventions are being promoted to improve glycemic control in type 2 diabetes mellitus (T2D), but limited randomized trial (RCT) data exist. We evaluated the efficacy of a scalable, technology-based grocery prescription program in low-income, high-risk adults with T2D.Methods: We conducted a 1:1 RCT in Kaiser Permanente Northern & Southern […]
Read More1249-OR: Medically Tailored Meals Lower Hemoglobin A1c: The Food as Medicine for Diabetes (FAME-D) Randomized Clinical Trial
Introduction and Objective: Food insecurity leads to worse type 2 diabetes (T2D) outcomes, but which food insecurity intervention best improves T2D outcomes is unclear. Our objective was to compare the effectiveness of two food insecurity interventions: medically tailored meals (MTM) and food subsidies.Methods: Randomized comparative effectiveness trial (NCT04828785). Adults with T2D and food insecurity received […]
Read More1244-OR: Long Noncoding RNA: A New Partaker in the Removal of the Damaged Mitochondria in Diabetic Retinopathy
Introduction and Objective: Diabetes damages retinal mitochondria and impairs their removal by mitophagy, and these damaged mitochondria continue to accumulate. Diabetes also results in aberrant expression of many long noncoding RNAs (LncRNAs), the RNA transcripts with >200 nucleotides. These noncoding RNAs can interact with RNA, DNA and proteins, regulating many physiological processes. Among them, LncRNA […]
Read More1276-OR: GLP-1R Agonists Increase Irisin Levels in Patients with T2D through PKA/CREB-Dependent Muscle Stimulation
Introduction and Objective: Irisin is a hormone secreted by skeletal muscle following physical activity or exposure to excess saturated fatty acids, promoting energy expenditure and insulin secretion. Circulating irisin levels are reduced in patients with type 2 diabetes (T2D), while exogenous irisin administration improves glycemic control in diabetic mice. Interestingly, irisin and GLP-1 share pleiotropic […]
Read More1236-OR: Antenatal Continuous Glucose Monitoring and Perinatal Outcomes in Pregnancies Complicated by Type 2 Diabetes
Introduction and Objective: We compared perinatal outcomes among pregnancies complicated by type 2 diabetes (T2D) managed with continuous glucose monitoring (CGM) to self-monitored blood glucose (SMBG).Methods: Patients with pre-pregnancy T2D, singleton gestation, and delivery between 2018-2024 at two health systems were identified by ICD-10 codes. Patient demographics and outcomes were abstracted and compared between those […]
Read More